US study suggests universal vaccination of children with pneumococcal conjugate vaccine is beneficial for adults.
Doroshenko
Alexander
A
Health Protection Agency Centre for Infections, London, United Kingdom. alexander.doroshenko@hpa.org.uk
D000328:Adult; D002648:Child; D015897:Comorbidity; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D006801:Humans; D015994:Incidence; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D022401:Meningococcal Vaccines / Q000008:administration & dosage*; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011159:Population Surveillance; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000706:statistics & numerical data*
D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines